Panel Biomanufacturing Strategy track
Future-proofing Manufacturing for Commercialization of Allogeneic Cell Therapies: From Phase II to Global Commercialization
Tue, Nov 10, 2026 · 2:00–2:25 PM CET Biomanufacturing Strategy Stage, Koelnmesse
About this session
Selecting strategies for commercially viable, future-proof products through multi-regional scale-up Strategic timing and decision framework for manufacturing finalization at Phase II completion Navigating CMC requirements across FDA, EMA, and global regulatory jurisdictions Vendor based partnership - importance for business continuity and scaling Technology transfer and process validation strategies for commercial-scale production Capacity planning and manufacturing network design for global market launch Risk mitigation approaches for maintaining process flexibility while meeting regulatory…
Speaker
-
CSO NextCell Pharma and CEO QVance · NextCell Pharma
Panelist